# FDA 483 - Peter Gottlieb, MD - January 11, 2021

Source: https://www.keypedia.com/records/483/peter-gottlieb-md/39ba6e1e-8a30-46dc-9738-c3c68bcd9cb3

> FDA 483 for Peter Gottlieb, MD on January 11, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Peter Gottlieb, MD
- Inspection Date: 2021-01-11
- Product Type: drugs
- Office Name: Denver District Office
- Summary: An FDA inspection of Peter Gottlieb, MD, a Clinical Investigator in Aurora, CO, revealed significant deficiencies in the conduct of clinical investigations. Observations included failure to adhere to the investigational plan, lack of proper approvals for medical procedures, and inadequate oversight of study staff. The firm also failed to maintain accurate and complete case histories, with issues such as missing lab data and incorrect dating of lab reviews.

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/courtney-r-bratina/3ad4bfd5-d0da-4801-8e90-a5a3ba9291c3)

Company: https://www.keypedia.com/companies/peter-gottlieb-md/eb1b5f9f-e843-46bb-aa2e-810ab8ecf105

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face